Motley Bio is a pioneering deeptech company that is digitizing biology through multiomics, focusing on unlocking early disease biology and detection. The company's innovative multi-analyte sequencing technology, Trinity MPU, simultaneously profiles DNA, RNA, and proteins in a single readout, providing comprehensive analysis of a sample's genome, epigenome, transcriptome, and proteome for applications in diagnostics, therapeutics, and early cancer detection.